Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 21, 2022; 28(31): 4299-4309
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4299
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4299
Figure 1 Siewert classification of adenocarcinoma of the esophagogastric junction and recommended surgical options[3,4,28,29].
The tumors that centered 1-5 cm above esophagogastric junction (EGJ) are defined as Siewert type I, transthoracic esophagectomy is recommended. the tumors centered from 1 cm above to 2 cm below the EGJ are Siewert type II. For Siewert type II tumor with esophageal invasion ≥ 3 cm, Ivor-Lewis esophagectomy with upper/middle mediastinal lymphadenectomy is propriate surgical option; for esophageal invasion < 3 cm, extended proximal transhiatal gastrectomy or extended total trashiatal gastrectomy with lower mediastinal lymphadenectomy are recommended according to whether gastric invasion exceeded 1/3 of the stomach. The tumors that centered 2-5 cm below EGJ are defined as Siewert type III and extended total gastrectomy is the optimal surgical option. EGJ: Esophagogastric junction.
- Citation: Zheng YH, Zhao EH. Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction. World J Gastroenterol 2022; 28(31): 4299-4309
- URL: https://www.wjgnet.com/1007-9327/full/v28/i31/4299.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i31.4299